Your browser is no longer supported. Please, upgrade your browser.
Settings
AMPH Amphastar Pharmaceuticals, Inc. daily Stock Chart
AMPH [NASD]
Amphastar Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-0.21 Insider Own6.50% Shs Outstand47.04M Perf Week1.10%
Market Cap777.57M Forward P/E13.68 EPS next Y1.21 Insider Trans-2.29% Shs Float35.24M Perf Month-1.43%
Income-10.00M PEG- EPS next Q0.07 Inst Own45.80% Short Float4.20% Perf Quarter-12.82%
Sales241.90M P/S3.21 EPS this Y-117.60% Inst Trans-0.29% Short Ratio6.47 Perf Half Y-8.98%
Book/sh7.03 P/B2.35 EPS next Y217.89% ROA-0.80% Target Price23.00 Perf Year-7.34%
Cash/sh1.22 P/C13.57 EPS next 5Y25.00% ROE-1.10% 52W Range14.40 - 20.45 Perf YTD-14.09%
Dividend- P/FCF- EPS past 5Y-15.90% ROI-1.10% 52W High-19.17% Beta1.34
Dividend %- Quick Ratio1.50 Sales past 5Y3.30% Gross Margin35.20% 52W Low14.79% ATR0.45
Employees1644 Current Ratio2.40 Sales Q/Q3.00% Oper. Margin-5.00% RSI (14)55.63 Volatility2.71% 2.84%
OptionableYes Debt/Eq0.14 EPS Q/Q-938.40% Profit Margin-1.50% Rel Volume1.00 Prev Close16.67
ShortableYes LT Debt/Eq0.12 EarningsAug 08 AMC Payout- Avg Volume228.68K Price16.53
Recom2.00 SMA201.84% SMA50-0.21% SMA200-9.26% Volume228,957 Change-0.84%
Mar-13-18Reiterated Needham Buy $23 → $24
Dec-01-17Reiterated Needham Buy $20 → $23
Nov-09-17Downgrade Raymond James Outperform → Mkt Perform
Sep-27-17Reiterated Needham Buy $18 → $20
Mar-14-17Downgrade Raymond James Strong Buy → Outperform
Aug-09-16Reiterated Needham Buy $20 → $22
May-10-16Reiterated Needham Buy $21 → $20
Feb-19-16Initiated Wells Fargo Outperform
Jun-19-15Reiterated Needham Buy $17 → $21
Jun-03-15Initiated Raymond James Strong Buy
Jul-21-14Initiated Needham Buy $17
Jul-09-18 06:00AM  Amphastar Announces Expansion of Amphastar Nanjing Pharmaceuticals Inc. GlobeNewswire
Jul-02-18 09:30AM  AGN vs. AMPH: Which Stock Is the Better Value Option? Zacks
Jun-19-18 06:00AM  Amphastar Announces Approval for Isoproterenol Hydrochloride Injection, USP GlobeNewswire
Jun-14-18 08:01AM  New Strong Sell Stocks for June 14th Zacks
Jun-05-18 08:00AM  Consolidated Research: 2018 Summary Expectations for Summit Therapeutics, Orbotech, Amphastar Pharmaceuticals, Mizuho Financial Group, Endo International plc, and AXT Fundamental Analysis, Key Performance Indications GlobeNewswire
05:21AM  Moving Average Crossover Alert: Amphastar Pharmaceuticals, Inc. (AMPH) Zacks
Jun-04-18 04:05PM  Amphastar Pharmaceuticals to Present at the Jefferies Healthcare Conference 2018 GlobeNewswire
06:00AM  Amphastar Pharmaceuticals Receives FDA Approval for Semi-Purified Heparin at Amphastar Nanjing Pharmaceuticals GlobeNewswire
Jun-01-18 08:18AM  New Strong Sell Stocks for June 1st Zacks
May-31-18 06:42PM  Amphastar Pharmaceuticals Inc (NASDAQ:AMPH): Should The Recent Earnings Drop Worry You? Simply Wall St.
May-29-18 08:56AM  New Strong Sell Stocks for May 29th Zacks
May-22-18 10:23AM  New Strong Sell Stocks for May 22nd Zacks
May-18-18 08:39AM  Falling Earnings Estimates Signal Weakness Ahead for Amphastar (AMPH) Zacks
May-16-18 03:23PM  How Should You Think About Amphastar Pharmaceuticals Incs (NASDAQ:AMPH) Risks? Simply Wall St.
May-15-18 08:44AM  Benzinga's Daily Biotech Pulse: Aytu Rallies On Earnings, Evolus Awaits FDA Verdict, BofA Conference Underway Benzinga
08:19AM  New Strong Sell Stocks for May 15th Zacks
May-14-18 09:41PM  Edited Transcript of AMPH earnings conference call or presentation 9-May-18 9:00pm GMT Thomson Reuters StreetEvents +8.12%
06:00AM  Amphastar Pharmaceuticals Receives FDA Approval for Calcium Chloride Injection GlobeNewswire
May-10-18 06:00AM  Amphastar Pharmaceuticals to Present at the Bank of America Merrill Lynch Health Care Conference 2018 GlobeNewswire -24.70%
May-09-18 06:23PM  Amphastar: 1Q Earnings Snapshot Associated Press
04:05PM  Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2018 GlobeNewswire
May-03-18 04:05PM  Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 9, 2018 GlobeNewswire
Apr-27-18 05:22PM  Is Amphastar Pharmaceuticals Incs (NASDAQ:AMPH) Balance Sheet Strong Enough To Weather A Storm? Simply Wall St.
Apr-12-18 08:30AM  Consolidated Research: 2018 Summary Expectations for Insight Enterprises, Amphastar Pharmaceuticals, EMC Insurance Group, Prothena Corporation plc, Mizuho Financial Group, and Baytex Energy Fundamental Analysis, Key Performance Indications GlobeNewswire
Apr-04-18 10:55AM  What Is Amphastar Pharmaceuticals Incs (NASDAQ:AMPH) Share Price Doing? Simply Wall St.
Mar-28-18 09:08AM  Is Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) A Sell At Its Current PE Ratio? Simply Wall St.
Mar-26-18 06:00AM  Amphastar Pharmaceuticals to Present at the Needhams 17th Annual Healthcare Conference GlobeNewswire
Mar-21-18 06:00AM  Amphastar Announces Final Judgment in the Patent Litigation against Momenta Pharmaceuticals, Inc. and Sandoz Inc. GlobeNewswire
Mar-20-18 07:50AM  Blog Exposure - Dr. Reddys Launches its Levocetirizine Dihydrochloride Tablets in the US Market ACCESSWIRE
Mar-15-18 07:45AM  Market Trends Toward New Normal in Golden Ocean Group, Redhill Biopharma, Galapagos NV, Crawford, Amphastar Pharmaceuticals, and 51job Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Mar-14-18 11:42AM  Amphastar Pharmaceuticals (AMPH) Q4 2017 Earnings Conference Call Transcript Motley Fool
Mar-13-18 07:21PM  Edited Transcript of AMPH earnings conference call or presentation 12-Mar-18 9:00pm GMT Thomson Reuters StreetEvents
Mar-12-18 04:29PM  Amphastar beats Street 4Q forecasts Associated Press
04:05PM  Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Fiscal Year Ended December 31, 2017 GlobeNewswire
08:41AM  Amphastar Pharmaceutical Q4 Earnings Preview Benzinga
Mar-07-18 11:02AM  Best Growth Stock Picks Simply Wall St.
Mar-05-18 04:01PM  Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on March 12, 2018 GlobeNewswire
Mar-01-18 05:15PM  Should You Be Concerned About Amphastar Pharmaceuticals Incs (NASDAQ:AMPH) -98.57% Earnings Decline? Simply Wall St.
Feb-28-18 08:56AM  Mallinckrodt PLC (MNK) Jumps: Stock Rises 15.3% Zacks
Feb-21-18 05:58PM  How Did Amphastar Pharmaceuticals Incs (NASDAQ:AMPH) 0.09% ROE Fare Against The Industry? Simply Wall St.
08:09AM  Is a Beat in Store for Inogen (INGN) This Earnings Season? Zacks
Feb-09-18 10:45AM  AmerisourceBergen (ABC) Gains on World Courier Unit Strength Zacks
Jan-30-18 08:26AM  What's in Store for Cardinal Health (CAH) in Q2 Earnings? Zacks
Jan-09-18 06:43AM  How Financially Strong Is Amphastar Pharmaceuticals Inc (NASDAQ:AMPH)? Simply Wall St.
Jan-01-18 04:55PM  An Intrinsic Value Calculation For Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) Shows Its 39.91% Undervalued Simply Wall St.
09:14AM  Amphastar Pharmaceuticals, Inc. :AMPH-US: Earnings Analysis: Q3, 2017 By the Numbers : January 1, 2018 Capital Cube
Dec-22-17 07:35PM  Should You Buy Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) At $19.5? Simply Wall St.
Dec-21-17 07:20AM  Wired News Amphastar Pharmaceuticals Declares Approval of ANDA for Sodium Nitroprusside Injection ACCESSWIRE
Dec-19-17 06:00AM  Amphastar Announces Approval for Sodium Nitroprusside Injection, USP GlobeNewswire
Dec-12-17 07:22AM  Amphastar Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : AMPH-US : December 12, 2017 Capital Cube
Nov-29-17 02:50PM  Amphastar Announces Approval for Medroxyprogesterone Acetate Injectable Suspension, USP GlobeNewswire
12:50PM  Amphastar Pharmaceuticals, Inc. Value Analysis (NASDAQ:AMPH) : November 29, 2017 Capital Cube
Nov-28-17 07:51AM  Amphastar Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : AMPH-US : November 28, 2017 Capital Cube
Nov-23-17 04:21PM  What You Must Know About Amphastar Pharmaceuticals Incs (AMPH) 0.09% ROE Simply Wall St.
Nov-20-17 06:00AM  Amphastar Pharmaceuticals to Present at the 29th Annual Piper Jaffray Healthcare Conference GlobeNewswire
Nov-14-17 12:36PM  Edited Transcript of AMPH earnings conference call or presentation 8-Nov-17 10:00pm GMT Thomson Reuters StreetEvents
Nov-08-17 06:29PM  Should Amphastar Pharmaceuticals Incs (AMPH) Earnings Decline In Recent Times Worry You? Simply Wall St.
04:32PM  Amphastar beats Street 3Q forecasts Associated Press
04:05PM  Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2017 GlobeNewswire
Nov-02-17 11:43AM  ETFs with exposure to Amphastar Pharmaceuticals, Inc. : November 2, 2017 Capital Cube
Oct-31-17 06:00AM  Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 8, 2017 GlobeNewswire
Oct-23-17 10:19AM  ETFs with exposure to Amphastar Pharmaceuticals, Inc. : October 23, 2017 Capital Cube
Oct-04-17 10:31AM  ETFs with exposure to Amphastar Pharmaceuticals, Inc. : October 4, 2017 Capital Cube
Sep-25-17 06:51PM  Amphastar Announces Approval for Neostigmine Methylsulfate Injection, USP GlobeNewswire
Sep-22-17 11:03AM  ETFs with exposure to Amphastar Pharmaceuticals, Inc. : September 22, 2017 Capital Cube
08:05AM  Amphastar Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : AMPH-US : September 22, 2017 Capital Cube
Sep-21-17 10:10AM  FDA OKs BioCryst's Rapivab for Pediatric Indication - Biotech Movers TheStreet.com
Sep-20-17 04:22PM  Amphastar Pharmaceuticals Receives FDA Approval for Sodium Bicarbonate Injection GlobeNewswire
Sep-11-17 08:19PM  ETFs with exposure to Amphastar Pharmaceuticals, Inc. : September 12, 2017 Capital Cube
Sep-08-17 03:49PM  Amphastar Pharmaceuticals, Inc. :AMPH-US: Earnings Analysis: Q2, 2017 By the Numbers : September 8, 2017 Capital Cube
07:30AM  Featured Company News - Dr. Reddy's Labs Announces the Launch of Anti-Depressant and Muscle Relaxant Tablets in the US ACCESSWIRE
Aug-30-17 06:00AM  Amphastar Pharmaceuticals to Present at the 2017 Wells Fargo Securities Healthcare Conference GlobeNewswire
Aug-15-17 05:33PM  Amphastar Pharmaceuticals, Inc. Value Analysis (NASDAQ:AMPH) : August 15, 2017 Capital Cube
Aug-13-17 09:10AM  Edited Transcript of AMPH earnings conference call or presentation 9-Aug-17 9:00pm GMT Thomson Reuters StreetEvents
Aug-11-17 07:12AM  Trump Declares Opioid Crisis National Emergency - These 6 Drug Makers Can Help TheStreet.com
Aug-09-17 09:52PM  Amphastar beats 2Q profit forecasts Associated Press
04:05PM  Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2017 GlobeNewswire
04:00PM  Investor Network: Amphastar Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
Aug-02-17 06:00AM  Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 9, 2017 GlobeNewswire
Aug-01-17 09:17AM  Amphastar Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : AMPH-US : August 1, 2017 Capital Cube
Jul-24-17 06:00AM  Amphastar Announces Jury Verdict in Patent Litigation against Momenta Pharmaceuticals, Inc. and Sandoz Inc. GlobeNewswire
Jul-21-17 03:03PM  U.S. jury sides with Amphastar over Momenta in drug patent trial Reuters
03:00PM  Jury nixes Momenta patent case that sought $938M in damages American City Business Journals
12:41PM  U.S. jury sides with Amphastar over Momenta in drug patent trial Reuters
Jul-19-17 06:59PM  Cramer's lightning round: GameStop just can't seem to go ... CNBC Videos
06:48PM  Cramer's lightning round: GameStop just can't seem to go higher CNBC
Jul-13-17 03:27PM  ETFs with exposure to Amphastar Pharmaceuticals, Inc. : July 13, 2017 Capital Cube
Jul-03-17 02:50PM  ETFs with exposure to Amphastar Pharmaceuticals, Inc. : July 3, 2017 Capital Cube
Jun-19-17 02:53PM  ETFs with exposure to Amphastar Pharmaceuticals, Inc. : June 19, 2017 Capital Cube
Jun-09-17 01:15PM  ETFs with exposure to Amphastar Pharmaceuticals, Inc. : June 9, 2017 Capital Cube
Jun-08-17 08:54AM  Amphastar Pharmaceuticals, Inc. :AMPH-US: Earnings Analysis: Q1, 2017 By the Numbers : June 8, 2017 Capital Cube
Jun-01-17 04:05PM  Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference GlobeNewswire
May-30-17 08:45AM  Amphastar (AMPH) in Focus: Stock Moves 9.7% Higher Zacks
May-12-17 09:15PM  Edited Transcript of AMPH earnings conference call or presentation 8-May-17 9:00pm GMT Thomson Reuters StreetEvents
May-10-17 06:00AM  Amphastar Pharmaceuticals to Present at the 20th Annual Bank of America Merrill Lynch Health Care Conference GlobeNewswire
May-08-17 05:51PM  Amphastar beats 1Q profit forecasts Associated Press
04:05PM  Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2017 GlobeNewswire
12:00PM  Investor Network: Amphastar Pharmaceuticals, Inc. to Host Earnings Call Accesswire
May-04-17 12:14PM  Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 8, 2017 GlobeNewswire
06:00AM  Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on May 8, 2017 GlobeNewswire
Amphastar Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States and internationally. It operates through two segments, Finished Pharmaceutical Products and Active Pharmaceutical Ingredients. The company offers enoxaparin, a low molecular weight heparin that is used as an anticoagulant for the prevention and treatment of deep vein thrombosis; naloxone for opioid overdose; Cortrosyn, a lyophilized powder for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency; Amphadase, a bovine-sourced hyaluronidase injection to absorb and disperse other injected drugs; and lidocaine jelly, a local anesthetic product for urological procedures. It also provides lidocaine topical solution for various procedures; phytonadione injection for newborn babies; syringe products, such as morphine, atropine, calcium chloride, dextrose, epinephrine, lidocaine, and sodium bicarbonate for emergency use in hospital settings; lorazepam injection for surgery and medical procedures; ketorolac for acute pain management; procainamide for documented ventricular arrhythmias; medroxyprogesterone acetate injectable suspension for the prevention of pregnancy. In addition, the company manufactures and distributes recombinant human and porcine insulins. Further, it develops Primatene Mist, an over-the-counter epinephrine inhalation product candidate for the temporary relief of mild symptoms of intermittent asthma. Additionally, the company has a pipeline of 20 generic and proprietary product candidates in various stages of development for various indications. Its products are used in hospital or urgent care clinical settings, and primarily contracted and distributed through group purchasing organizations and drug wholesalers. Amphastar Pharmaceuticals, Inc. was founded in 1996 and is headquartered in Rancho Cucamonga, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Shandell Jason B.President and General CounselJul 11Sale16.7714,399241,422199,505Jul 12 05:53 PM
PETERS WILLIAM JCFO, SVP & TreasurerJul 09Sale16.463,25053,49889,243Jul 11 04:03 PM
Zhang Jack Y.CEO & Chief Scientific OfficerJul 02Option Exercise12.02186,5452,242,8311,532,674Jul 03 05:06 PM
Zhang Jack Y.CEO & Chief Scientific OfficerJul 02Option Exercise12.02319,7913,844,8472,400,410Jul 03 05:06 PM
ZASLOFF MICHAEL ADirectorJun 12Sale16.5215,000247,84229,845Jun 13 04:05 PM
Zhang Jack Y.CEO & Chief Scientific OfficerMay 16Buy16.0615,000240,8542,080,619May 17 07:05 PM
Zhang Jack Y.CEO & Chief Scientific OfficerMay 15Buy16.0825,000401,9702,065,619May 17 07:05 PM
Shandell Jason B.President and General CounselMar 20Sale19.528,293161,871224,886Mar 20 08:02 PM
Shandell Jason B.President and General CounselMar 19Sale19.3711,707226,767233,179Mar 20 08:02 PM
PRINS RICHARD KDirectorMar 15Option Exercise14.6616,598243,32745,442Mar 16 06:19 PM
PRINS RICHARD KDirectorMar 15Sale19.9016,598330,31828,844Mar 16 06:19 PM
Shandell Jason B.President and General CounselMar 14Option Exercise11.794004,716217,348Mar 15 04:15 PM
Shandell Jason B.President and General CounselMar 14Sale20.454008,180216,948Mar 15 04:15 PM
PETERS WILLIAM JCFO, SVP & TreasurerMar 13Option Exercise11.3319,801224,34598,115Mar 15 04:16 PM
Shandell Jason B.President and General CounselMar 13Option Exercise11.793003,537217,248Mar 15 04:15 PM
Shandell Jason B.President and General CounselMar 13Sale20.453006,135216,948Mar 15 04:15 PM
PETERS WILLIAM JCFO, SVP & TreasurerMar 13Sale20.1019,801398,00478,314Mar 15 04:16 PM
Shandell Jason B.President and General CounselJan 26Sale19.569,966194,925216,948Jan 26 06:02 PM
Shandell Jason B.President and General CounselJan 25Sale19.268,661166,822226,914Jan 26 06:02 PM
Gerst Diane G.EVP, QA & Regulatory AffairsDec 19Sale19.4852310,18630,164Dec 19 06:28 PM
Zhang Jack Y.CEO & Chief Scientific OfficerDec 15Option Exercise12.02373,0914,485,6731,636,469Dec 19 06:25 PM
Zhang Jack Y.CEO & Chief Scientific OfficerDec 15Option Exercise12.02639,5847,689,7182,537,431Dec 19 06:25 PM
Shohet Stephen B.DirectorDec 14Option Exercise10.777,86684,71731,982Dec 14 08:03 PM
Shohet Stephen B.DirectorDec 14Sale18.877,866148,43024,116Dec 14 08:03 PM
Gerst Diane G.EVP, QA & Regulatory AffairsDec 12Sale18.965239,91730,687Dec 14 08:02 PM
Shohet Stephen B.DirectorDec 07Option Exercise10.777,86284,67431,978Dec 08 04:30 PM
Shohet Stephen B.DirectorDec 07Sale18.347,862144,21024,116Dec 08 04:30 PM
PETERS WILLIAM JCFO, SVP & TreasurerDec 01Sale19.676,226122,46578,314Dec 05 04:30 PM
Shohet Stephen B.DirectorNov 30Option Exercise10.777,86284,67431,978Nov 30 07:38 PM
Shohet Stephen B.DirectorNov 30Sale19.257,862151,34424,116Nov 30 07:38 PM
Gerst Diane G.EVP, QA & Regulatory AffairsNov 28Sale18.155239,49331,210Nov 30 07:37 PM
Shohet Stephen B.DirectorNov 22Option Exercise10.777,86284,67431,978Nov 24 08:00 PM
Shohet Stephen B.DirectorNov 22Sale18.947,862148,89524,116Nov 24 08:00 PM
Gerst Diane G.EVP, QA & Regulatory AffairsNov 21Sale18.815239,83931,733Nov 21 05:21 PM
Shohet Stephen B.DirectorNov 16Option Exercise10.777,86284,67431,978Nov 17 08:02 PM
Shohet Stephen B.DirectorNov 16Sale18.047,862141,86224,116Nov 17 08:02 PM
Gerst Diane G.EVP, QA & Regulatory AffairsNov 15Sale17.775239,29232,256Nov 17 08:01 PM
Shohet Stephen B.DirectorNov 09Option Exercise10.777,86284,67431,978Nov 09 09:04 PM
Shohet Stephen B.DirectorNov 09Sale18.557,862145,84524,116Nov 09 09:04 PM
Gerst Diane G.EVP, QA & Regulatory AffairsNov 07Sale17.935239,37532,779Nov 09 09:00 PM
Shohet Stephen B.DirectorNov 02Option Exercise10.777,86284,67431,978Nov 03 04:05 PM
Shohet Stephen B.DirectorNov 02Sale18.377,862144,46024,116Nov 03 04:05 PM
Shohet Stephen B.DirectorOct 26Option Exercise10.777,86284,67431,978Oct 26 06:21 PM
Shohet Stephen B.DirectorOct 26Sale18.397,862144,61824,116Oct 26 06:21 PM
Gerst Diane G.EVP, QA & Regulatory AffairsOct 24Sale18.295239,56833,302Oct 26 06:20 PM
Shohet Stephen B.DirectorOct 19Option Exercise10.777,86284,67431,978Oct 19 08:01 PM
Shohet Stephen B.DirectorOct 19Sale18.347,862144,19524,116Oct 19 08:01 PM
Gerst Diane G.EVP, QA & Regulatory AffairsOct 17Sale18.485239,66533,825Oct 19 08:00 PM
PETERS WILLIAM JCFO, SVP & TreasurerOct 13Sale18.563,02656,17683,496Oct 13 08:00 PM
Shohet Stephen B.DirectorOct 12Option Exercise10.777,86284,67431,978Oct 13 08:02 PM
Shohet Stephen B.DirectorOct 12Sale18.737,862147,21924,116Oct 13 08:02 PM
Gerst Diane G.EVP, QA & Regulatory AffairsOct 05Option Exercise11.338,44495,67142,792Oct 06 05:54 PM
Gerst Diane G.EVP, QA & Regulatory AffairsOct 05Sale18.878,444159,37634,348Oct 06 05:54 PM
Petersen Floyd F.DirectorOct 04Option Exercise10.7739,312423,390103,873Oct 06 05:52 PM
Petersen Floyd F.DirectorOct 04Sale18.5939,312730,75564,561Oct 06 05:52 PM
ZASLOFF MICHAEL ADirectorOct 02Option Exercise10.7763,624685,230101,879Oct 03 06:18 PM
ZASLOFF MICHAEL ADirectorOct 02Sale18.1863,6241,156,95238,255Oct 03 06:18 PM
PRINS RICHARD KDirectorAug 15Option Exercise10.775,00053,85033,844Aug 16 06:57 PM
PRINS RICHARD KDirectorAug 15Sale14.825,00074,08728,844Aug 16 06:57 PM
PRINS RICHARD KDirectorAug 14Option Exercise10.775,00053,85033,844Aug 16 06:57 PM
PRINS RICHARD KDirectorAug 14Sale14.805,00073,99728,844Aug 16 06:57 PM